EUROPE GENETIC TESTING MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE GENETIC TESTING MARKET FORECAST 2019-2027

EUROPE GENETIC TESTING MARKET FORECAST 2019-2027

The global genetic testing market by Europe was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.33% during the forecast period. Healthcare expenditure in Europe is showing mixed scenarios. Post-2008 economic recession, immigration, and an aging population have impacted healthcare expenditure for a short period in Europe. Devaluation of Euro and economic pressure has resulted in limiting healthcare expenditure.

EUROPE GENETIC TESTING MARKET FORECAST 2019-2027

Request free sample

Genetic testing can reveal changes or alterations in the genes that may cause illness or disease. Genetic testing is experiencing a huge shift from general diagnostics to risk assessment situations.

The global genetic testing market by Europe was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.33% during the forecast period.

Healthcare expenditure in Europe is showing mixed scenarios. Post-2008 economic recession, immigration, and an aging population have impacted healthcare expenditure for a short period in Europe. Devaluation of Euro and economic pressure has resulted in limiting healthcare expenditure. However, taking a broader view, healthcare expenditure in Europe in the last three decades has increased significantly. Healthcare spending is increased rapidly than economic growth in Europe. Rheumatism/arthritis, diabetes, cancer, asthma, and hypertension are amongst the leading chronic diseases with high prevalence rates in Europe.

The economies of the United Kingdom, Germany, France, Italy, Spain and the Rest of Europe have been influencing the market growth in Europe. Overall, the market opportunity for the DTC genetic testing segment is low in Germany, but over the forecast period, high growth is expected in the genetic testing market, making it one of the chief market in the region.

Qiagen N.V., Genentech, Inc., Danaher Corporation (Cepheid), Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., Luminex Corporation, HTG Molecular Diagnostics, Inc., 23ANDME, DAAN Diagnostics Ltd., Natera, Inc., PerkinElmer, Inc., Illumina, Inc., Integragen S.A, Pacific Biosciences of California, Inc., Roche Diagnostics Corporation, Genomictree, Inc., Laboratory Corporation of America Holdings, Oxford Biodynamics Limited, Abbott Laboratories, and others have been the established contenders in the genetic testing market.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • MOLECULAR TESTING IS THE FASTEST GROWING GENETIC TESTING TECHNOLOGY
      • CANCER MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DISEASE
      • DIAGNOSTIC TESTING IS THE WIDELY USED GENETIC TESTING TYPE
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVER
      • GROWING USAGE OF DIAGNOSING GENETIC DISORDERS
      • RISE IN INCIDENCE OF GENETIC DISEASES
      • MINIMAL HEALTH RISK ASSOCIATED WITH GENETIC TESTING
      • SURGE IN RNA PIPELINE TESTS
      • ADVANCES IN GENETIC TESTING FOR CANCER
      • GROWING AGEING POPULATION
    • MARKET RESTRAINTS
      • INACCURACIES IN RESULTS
      • REIMBURSEMENT ISSUES
      • PSYCHOLOGICAL IMPACT
      • LACK OF PRECISION IN TESTING
    • MARKET OPPORTUNITIES
      • GENETIC COUNSELLING
      • RISING CLINICAL APPLICATION FOR GENETIC TESTING
      • INNOVATION IN THE TREATMENT AND DIAGNOSTIC
    • MARKET CHALLENGES
      • HIGH COST OF MEDICATION AND TESTS
      • HIGH COST OF RAW MATERIAL
      • RISE IN GENETIC DISCRIMINATION
  1. MARKET BY TECHNOLOGY
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
    • MOLECULAR TESTING
  2. MARKET BY TYPE
    • CARRIER TESTING
    • DIAGNOSTIC TESTING
    • NEWBORN SCREENING
    • PREDICTIVE AND PRESYMPTOMATIC TESTING
    • PRENATAL TESTING
    • OTHER TYPES
  3. MARKET BY DISEASE
    • ALZHEIMER’S DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • SICKLE CELL ANEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • THALASSEMIA
    • HUNTINGTON’S DISEASE
    • RARE DISEASES
    • OTHER DISEASES
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF RIVALRY
    • KEY BUYING CRITERIA
      • COST
      • ACCURACY
      • AVAILABILITY
      • RELIABILITY
    • MARKET TRENDS
      • HEALTH INFORMATION IS RISING SIGNIFICANTLY
      • INCREASING DEMAND FOR PERSONALIZED MEDICINE
      • NEW PRODUCT LAUNCHES
      • TECHNOLOGY ADVANCEMENTS
    • PESTEL ANALYSIS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHIC ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. COMPANY PROFILING
    • 23ANDME
    • ABBOTT LABORATORIES
    • BIO-RAD LABORATORIES, INC.
    • DANAHER CORPORATION (CEPHEID)
    • DAAN DIAGNOSTICS LTD.
    • GENENTECH, INC
    • HTG MOLECULAR DIAGNOSTICS, INC.
    • ILLUMINA, INC
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • LUMINEX CORPORATION
    • MYRIAD GENETICS, INC.
    • NATERA, INC.
    • OXFORD BIODYNAMICS LIMITED
    • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    • PERKINELMER, INC.
    • QIAGEN N.V.
    • ROCHE DIAGNOSTICS CORPORATION

 

TABLE LIST

TABLE 1        EUROPE GENETIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 2        COST OF SELECTED DRUGS IN CANCER THERAPY

TABLE 3        EUROPE GENETIC TESTING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 4        EUROPE CYTOGENETIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 5        EUROPE BIOCHEMICAL TESTING MARKET 2019-2027 ($ MILLION)

TABLE 6        EUROPE MOLECULAR TESTING MARKET 2019-2027 ($ MILLION)

TABLE 7        EUROPE GENETIC TESTING MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        EUROPE CARRIER TESTING MARKET 2019-2027 ($ MILLION)

TABLE 9        EUROPE DIAGNOSTIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 10      EUROPE NEWBORN SCREENING MARKET 2019-2027 ($ MILLION)

TABLE 11      EUROPE PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 12      EUROPE PRENATAL TESTING MARKET 2019-2027 ($ MILLION)

TABLE 13      EUROPE OTHER TYPES MARKET 2019-2027 ($ MILLION)

TABLE 14      EUROPE GENETIC TESTING MARKET BY DISEASE 2019-2027 ($ MILLION)

TABLE 15      EUROPE ALZHEIMER’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE 16      EUROPE CANCER MARKET 2019-2027 ($ MILLION)

TABLE 17      EUROPE CYSTIC FIBROSIS MARKET 2019-2027 ($ MILLION)

TABLE 18      EUROPE SICKLE CELL ANEMIA MARKET 2019-2027 ($ MILLION)

TABLE 19      EUROPE DUCHENNE MUSCULAR DYSTROPHY MARKET 2019-2027 ($ MILLION)

TABLE 20      EUROPE THALASSEMIA MARKET 2019-2027 ($ MILLION)

TABLE 21      EUROPE HUNTINGTON’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE 22      EUROPE RARE DISEASES MARKET 2019-2027 ($ MILLION)

TABLE 23      EUROPE OTHER DISEASES MARKET 2019-2027 ($ MILLION)

TABLE 24      EUROPE GENETIC TESTING MARKET BY COUNTRY 2019-2027

FIGURES LIST

FIGURE 1      EUROPE GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 2      SAMPLES TYPES IN GENETIC TESTING

FIGURE 3      LAB AUTOMATION TECHNOLOGY BENEFITS GENETIC DIAGNOSTIC INDUSTRIES

FIGURE 4      EUROPE GENETIC TESTING MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)

FIGURE 5      EUROPE GENETIC TESTING MARKET BY CYTOGENETIC TESTING 2019-2027 ($ MILLION)

FIGURE 6      EUROPE GENETIC TESTING MARKET BY BIOCHEMICAL TESTING 2019-2027 ($ MILLION)

FIGURE 7      EUROPE GENETIC TESTING MARKET BY MOLECULAR TESTING 2019-2027 ($ MILLION)

FIGURE 8      EUROPE GENETIC TESTING MARKET SHARE BY TYPE 2018 & 2027 (%)

FIGURE 9      EUROPE GENETIC TESTING MARKET BY CARRIER TESTING 2019-2027 ($ MILLION)

FIGURE 10   EUROPE GENETIC TESTING MARKET BY DIAGNOSTIC TESTING 2019-2027 ($ MILLION)

FIGURE 11   EUROPE GENETIC TESTING MARKET BY NEWBORN SCREENING 2019-2027 ($ MILLION)

FIGURE 12   EUROPE GENETIC TESTING MARKET BY PREDICTIVE AND PRESYMPTOMATIC TESTING 2019-2027 ($ MILLION)

FIGURE 13   EUROPE GENETIC TESTING MARKET BY PRENATAL TESTING 2019-2027 ($ MILLION)

FIGURE 14   EUROPE GENETIC TESTING MARKET BY OTHER TYPES 2019-2027 ($ MILLION)

FIGURE 15   EUROPE GENETIC TESTING MARKET SHARE BY DISEASE 2018 & 2027 (%)

FIGURE 16   EUROPE GENETIC TESTING MARKET BY ALZHEIMER’S DISEASE 2019-2027 ($ MILLION)

FIGURE 17   EUROPE GENETIC TESTING MARKET BY CANCER 2019-2027 ($ MILLION)

FIGURE 18   EUROPE GENETIC TESTING MARKET BY CYSTIC FIBROSIS 2019-2027 ($ MILLION)

FIGURE 19   EUROPE GENETIC TESTING MARKET BY SICKLE CELL ANEMIA 2019-2027 ($ MILLION)

FIGURE 20   EUROPE GENETIC TESTING MARKET BY DUCHENNE MUSCULAR DYSTROPHY 2019-2027 ($ MILLION)

FIGURE 21   EUROPE GENETIC TESTING MARKET BY THALASSEMIA 2019-2027 ($ MILLION)

FIGURE 22   EUROPE GENETIC TESTING MARKET BY HUNTINGTON’S DISEASE 2019-2027 ($ MILLION)

FIGURE 23   EUROPE GENETIC TESTING MARKET BY RARE DISEASES 2019-2027 ($ MILLION)

FIGURE 24   EUROPE GENETIC TESTING MARKET BY OTHER DISEASES 2019-2027 ($ MILLION)

FIGURE 25   PORTER’S FIVE FORCE MODEL

FIGURE 26   THE UNITED KINGDOM GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 27   FRANCE GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 28   GERMANY GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 29   SPAIN GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 30   ITALY GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 31   REST OF EUROPE GENETIC TESTING MARKET 2019-2027 ($ MILLION)

  1. GEOGRAPHIC ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
  1. MARKET BY TECHNOLOGY
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
    • MOLECULAR TESTING
  2. MARKET BY TYPE
    • CARRIER TESTING
    • DIAGNOSTIC TESTING
    • NEWBORN SCREENING
    • PREDICTIVE AND PRESYMPTOMATIC TESTING
    • PRENATAL TESTING
    • OTHER TYPES
  3. MARKET BY DISEASE
    • ALZHEIMER’S DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • SICKLE CELL ANEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • THALASSEMIA
    • HUNTINGTON’S DISEASE
    • RARE DISEASES
    • OTHER DISEASES

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now